Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indications for prothrombin complex concentrates in massive transfusions.

B Blauhut1

  • 1Red Cross Blood Transfusions Service, Linz, Austria. med.sekretariat@blutz.o.redcross.or.at

Thrombosis Research
|September 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transmission of hepatitis C by ozone enrichment of autologous blood.

Lancet (London, England)·1996
Same author

Hepatitis C virus--does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1995
Same author

Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.

The Journal of thoracic and cardiovascular surgery·1994
Same author

[Drug modification of blood loss].

Klinische Anasthesiologie und Intensivtherapie·1993
Same author

[Autotransfusion system II: collection, filtration and retransfusion of blood].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same author

[Comparison of 7 anti-hepatitis C virus enzyme immunoassays of the 2nd generation in blood donation services].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Massive transfusions are crucial for severe bleeding but can cause clotting disorders. This study outlines a transfusion regimen using platelet concentrates and fresh frozen plasma to minimize complications and support hemostasis.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Critical Care Medicine

Background:

  • Massive hemorrhage necessitates massive transfusions to preserve oxygen transport and hemostasis.
  • Inadequate transfusion strategies can lead to complex hemostatic disorders and generalized microvascular bleeding.

Purpose of the Study:

  • To describe an effective transfusion regimen for reducing complications associated with massive transfusions.
  • To highlight optimal blood product choices for hemostatic support in major bleeding events.

Main Methods:

  • Review and implementation of a specific transfusion protocol.
  • Utilizing platelet concentrates and fresh frozen plasma as primary hemostatic agents.
  • Consideration of prothrombin complex concentrates, antithrombin, and fibrinogen concentrates for specific patient needs.

Related Experiment Videos

Main Results:

  • The described transfusion regimen effectively reduces complications in patients undergoing massive transfusions.
  • Platelet concentrates and fresh frozen plasma are identified as the primary treatments for hemostatic support.
  • Supplementary agents are necessary in cases of localized bleeding, hepatic disease, or vitamin K deficiency.

Conclusions:

  • A structured transfusion regimen is vital for managing massive hemorrhage and preventing associated hemostatic complications.
  • Appropriate selection and administration of blood products, including concentrates, are key to successful hemostatic support.
  • Individualized treatment strategies are essential, considering patient-specific factors and bleeding characteristics.